Abstract
COVID-19 is a serious global health threat caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus enters human host cells through the recognition of angiotensin converting enzyme 2 (ACE2) receptors or cluster of differentiation 147 (CD147) via the virus’s spike glycoprotein. Once inside the cell, SARS-CoV-2 uses its genomic RNA as template to produce the two overlapping polyproteins, pp1a and pp1ab, that are subsequently cleaved into 16 nonstructural proteins (NSPs). NSPs then form a replication–transcription complex (RTC) to generate new viral RNA genomes and the mRNAs essential for viral replication. Thus, NSPs can be good targets for the development of antiviral drugs against SARS-CoV-2 infection. Here, we review the nonstructural proteins of SARS CoV 2, focusing on their protein structure and function.
Keywords
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19, Nonstructural proteins (NSPs), Antiviral